Nomura Research Institute (OTCMKTS:NRILY – Get Free Report)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $31.55, but opened at $33.66. Nomura Research Institute shares last traded at $33.66, with a volume of 365 shares.
Wall Street Analyst Weigh In
Separately, Zacks Research downgraded Nomura Research Institute from a “hold” rating to a “strong sell” rating in a report on Wednesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Nomura Research Institute presently has an average rating of “Hold”.
Read Our Latest Analysis on NRILY
Nomura Research Institute Stock Performance
Nomura Research Institute (OTCMKTS:NRILY – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.02). Nomura Research Institute had a return on equity of 4.38% and a net margin of 2.41%.The firm had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $206.14 billion. Equities research analysts predict that Nomura Research Institute will post 1.38 earnings per share for the current fiscal year.
About Nomura Research Institute
Nomura Research Institute, Ltd. (OTCMKTS:NRILY) is a Japanese consulting and information technology services company headquartered in Tokyo. The company helps businesses and government organizations address strategic, operational and technology-related challenges through management consulting, digital transformation services and systems integration.
NRI’s business includes financial IT solutions for banks, securities firms, asset managers and other financial institutions, as well as industrial IT solutions for companies in sectors such as retail, manufacturing and telecommunications.
Featured Articles
- Five stocks we like better than Nomura Research Institute
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Nomura Research Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nomura Research Institute and related companies with MarketBeat.com's FREE daily email newsletter.
